Insights

Innovative Therapeutics MannKind’s focus on inhaled therapies for endocrine and orphan lung diseases presents opportunities to collaborate with healthcare providers and pharmacies seeking advanced delivery systems for chronic and difficult-to-treat conditions.

Growth Through Acquisitions The recent acquisition of scPharmaceuticals and ongoing development of new inhalation therapies suggest expanding product pipelines, which can open up sales channels with hospitals, clinics, and specialty care centers focused on pulmonary and metabolic treatments.

Funding Momentum With significant recent financing of over 500 million dollars, MannKind is well-positioned to scale manufacturing, invest in sales infrastructure, and partner with distributors targeting niche markets within inhaled medicines and rare disease therapeutics.

Collaborative Development Strategic collaborations with companies like United Therapeutics indicate openness to joint innovation, creating opportunities for co-marketing and joint sales initiatives in targeted medical conditions and device technologies.

Technological Edge MannKind’s expertise in dry-powder and inhalation device technology offers a unique proposition to healthcare providers and medical device companies looking to enhance treatment adherence and improve delivery outcomes for respiratory and systemic therapies.

Similar companies to MannKind Corporation

MannKind Corporation Tech Stack

MannKind Corporation uses 8 technology products and services including HubSpot Analytics, Salesforce, Indeed, and more. Explore MannKind Corporation's tech stack below.

HubSpot Analytics
Analytics
Salesforce
Customer Relationship Management
Indeed
Human Resource Management System
React
Javascript Frameworks
Acquia Cloud Platform
Platform As A Service
Smartsheet
Project Management
Cloudflare Bot Management
Security
FedEx
Transportation And Fleet Management

Media & News

MannKind Corporation's Email Address Formats

MannKind Corporation uses at least 1 format(s):

MannKind Corporation Email Formats	Example	Percentage
FLast@mannkindcorp.com	JDoe@mannkindcorp.com	90%
FiLast@mannkindcorp.com	JoDoe@mannkindcorp.com	4%
First.Last@mannkindcorp.com	John.Doe@mannkindcorp.com	4%
FirstLast@mannkindcorp.com	JohnDoe@mannkindcorp.com	2%

Frequently Asked Questions

Where is MannKind Corporation's headquarters located?

MannKind Corporation's main headquarters is located at 1 Casper Street, Danbury, CT 06810-6903, US. The company has employees across 5 continents, including North AmericaAsiaEurope.

What is MannKind Corporation's phone number?

You can contact MannKind Corporation's main corporate office by phone at

+1-818-661-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is MannKind Corporation's official website and social media links?

MannKind Corporation's official website is mannkindcorp.com and has social profiles on LinkedIn Crunchbase.

What is MannKind Corporation's SIC code NAICS code?

MannKind Corporation's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does MannKind Corporation have currently?

As of October 2025, MannKind Corporation has approximately 606 employees across 5 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer, Professional Photographer, Graphic Design Artist And Sound Engineer: E. G.Chief Medical Officer: A. A.Chief Medical Officer: A. B.. Explore MannKind Corporation's employee directory with LeadIQ.

What industry does MannKind Corporation belong to?

MannKind Corporation operates in the Pharmaceutical Manufacturing industry.

What technology does MannKind Corporation use?

MannKind Corporation's tech stack includes HubSpot AnalyticsSalesforceIndeedReactAcquia Cloud PlatformSmartsheetCloudflare Bot ManagementFedEx.

What is MannKind Corporation's email format?

MannKind Corporation's email format typically follows the pattern of FLast@mannkindcorp.com. Find more MannKind Corporation email formats with LeadIQ.

When was MannKind Corporation founded?

MannKind Corporation was founded in 1991.

MannKind Corporation

Pharmaceutical ManufacturingUnited States501-1000 Employees

MannKind Corporation (Nasdaq: MNKD) focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases.

We are committed to using our formulation capabilities and device engineering prowess to lessen the burden of diseases such as diabetes, pulmonary arterial hypertension (PAH) and nontuberculous mycobacterial (NTM) lung disease. Our signature technologies – dry-powder formulations and inhalation devices – offer rapid and convenient delivery of medicines to the deep lung where they can exert an effect locally or enter the systemic circulation.

With a passionate team of Mannitarians collaborating nationwide, we are on a mission to give people control of their health and the freedom to live life.

Please visit mannkindcorp.com to learn more.